RU2003112608A - NEW RETINOIDS FOR TREATING EMPHYSEMA - Google Patents
NEW RETINOIDS FOR TREATING EMPHYSEMAInfo
- Publication number
- RU2003112608A RU2003112608A RU2003112608/04A RU2003112608A RU2003112608A RU 2003112608 A RU2003112608 A RU 2003112608A RU 2003112608/04 A RU2003112608/04 A RU 2003112608/04A RU 2003112608 A RU2003112608 A RU 2003112608A RU 2003112608 A RU2003112608 A RU 2003112608A
- Authority
- RU
- Russia
- Prior art keywords
- compound according
- compound
- alkyl
- hydrogen atom
- formula
- Prior art date
Links
- 206010014561 Emphysema Diseases 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims 68
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 32
- 125000000217 alkyl group Chemical group 0.000 claims 27
- 230000000875 corresponding Effects 0.000 claims 19
- -1 (-O) - Chemical class 0.000 claims 16
- 125000001072 heteroaryl group Chemical group 0.000 claims 14
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims 10
- 125000004404 heteroalkyl group Chemical group 0.000 claims 10
- 125000000623 heterocyclic group Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 7
- 125000002252 acyl group Chemical group 0.000 claims 6
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 239000000651 prodrug Substances 0.000 claims 6
- 229940002612 prodrugs Drugs 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000005242 carbamoyl alkyl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-Dichlorophenoxyacetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 208000003561 Respiratory Tract Disease Diseases 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000005418 aryl aryl group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 1
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 claims 1
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000012038 nucleophile Substances 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- SIYXOPPCTYVBMH-UHFFFAOYSA-N CC(C)(C)C1C=C(CCc(cc2)ccc2Cl)C(CN2NNC=C2)=CC1C(C)(C)C Chemical compound CC(C)(C)C1C=C(CCc(cc2)ccc2Cl)C(CN2NNC=C2)=CC1C(C)(C)C SIYXOPPCTYVBMH-UHFFFAOYSA-N 0.000 description 1
Claims (71)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23745900P | 2000-10-02 | 2000-10-02 | |
US60/237,459 | 2000-10-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2003112608A true RU2003112608A (en) | 2004-11-20 |
RU2282616C2 RU2282616C2 (en) | 2006-08-27 |
Family
ID=22893812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003112608/04A RU2282616C2 (en) | 2000-10-02 | 2001-09-24 | Novel retinoids for emphysema treatment |
Country Status (36)
Country | Link |
---|---|
US (1) | US6777418B2 (en) |
EP (1) | EP1324970B1 (en) |
JP (1) | JP4118675B2 (en) |
KR (1) | KR100682144B1 (en) |
CN (1) | CN1321101C (en) |
AR (1) | AR034156A1 (en) |
AT (1) | ATE413375T1 (en) |
AU (2) | AU8991301A (en) |
BR (1) | BRPI0114344B8 (en) |
CA (1) | CA2422805C (en) |
CY (1) | CY1109045T1 (en) |
CZ (1) | CZ307141B6 (en) |
DE (1) | DE60136477D1 (en) |
DK (1) | DK1324970T3 (en) |
EC (1) | ECSP034518A (en) |
ES (1) | ES2316471T3 (en) |
GT (1) | GT200100199A (en) |
HK (1) | HK1061229A1 (en) |
HR (1) | HRP20030230B1 (en) |
HU (1) | HU230063B1 (en) |
IL (2) | IL154810A0 (en) |
JO (1) | JO2434B1 (en) |
MA (1) | MA26950A1 (en) |
MX (1) | MXPA03002861A (en) |
MY (1) | MY137435A (en) |
NO (1) | NO329113B1 (en) |
NZ (1) | NZ524603A (en) |
PA (1) | PA8529701A1 (en) |
PL (1) | PL208665B1 (en) |
PT (1) | PT1324970E (en) |
RS (1) | RS50354B (en) |
RU (1) | RU2282616C2 (en) |
SI (1) | SI1324970T1 (en) |
TW (1) | TWI304805B (en) |
WO (1) | WO2002028810A2 (en) |
ZA (1) | ZA200301978B (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
EP1701934B1 (en) | 2003-12-26 | 2009-02-25 | Allergan, Inc. | DISUBSTITUTED CHALCONE OXIMES HAVING RAR(Gamma)-RETINOID RECEPTOR ANTAGONIST ACTIVITY |
US7476673B2 (en) * | 2003-12-30 | 2009-01-13 | Allergan, Inc. | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors |
GB2411115A (en) * | 2004-02-19 | 2005-08-24 | Medical Res Council | Retinoic acid antagonists for the treatment of oesophageal disorders |
JP4884963B2 (en) * | 2004-03-10 | 2012-02-29 | 財団法人乙卯研究所 | Memory retention promoter |
KR101026652B1 (en) * | 2006-03-31 | 2011-04-04 | 에프. 호프만-라 로슈 아게 | Process for preparing retinoid compounds |
EP2089017A2 (en) * | 2006-11-02 | 2009-08-19 | Aestus Therapeutics, Inc. | Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways |
TW201500053A (en) * | 2008-08-27 | 2015-01-01 | Otsuka Pharma Co Ltd | Agent for treating pulmonary disease |
EP2613776B1 (en) | 2010-09-01 | 2020-07-29 | Thomas Jefferson University | Composition and method for muscle repair and regeneration |
EP2918290B1 (en) * | 2012-11-08 | 2020-09-02 | Yamaguchi University | Therapeutic agent for keratoconjunctive disorders |
EP3446690A1 (en) | 2013-05-22 | 2019-02-27 | Yamaguchi University | Inhibitor for retinochoroidal disorders |
ES2595508T3 (en) * | 2014-10-15 | 2016-12-30 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Apixabán glycol esters as key intermediates and impurities of apixabán synthesis |
EP4098257A1 (en) | 2015-11-25 | 2022-12-07 | IO Therapeutics, Inc. | Use of cyp26-resistant rar alpha selective agonists in the treatment of cancer |
EP4249490A3 (en) | 2016-06-08 | 2023-12-13 | Clementia Pharmaceuticals Inc. | Methods for treating heterotopic ossification |
CN115671292A (en) | 2016-06-10 | 2023-02-03 | Io治疗公司 | Receptor selective retinoid and rexinoid compounds and immunomodulators for cancer immunotherapy |
KR20180036522A (en) * | 2016-09-30 | 2018-04-09 | (주)나노믹스 | Stilbene derivatives and preparation method thereof |
KR20190100187A (en) * | 2016-11-16 | 2019-08-28 | 클레멘티아 파마슈티컬즈, 인크. | How to Treat Multiple Osteochondroma (MO) |
EP3650448A4 (en) | 2017-07-06 | 2021-03-31 | Jiangsu Hengrui Medicine Co., Ltd. | Indole-formamide derivative, preparation method therefor and use thereof in medicine |
IL302133A (en) | 2017-07-13 | 2023-06-01 | Io Therapeutics Inc | Immunomodulatory retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy |
AU2018326617B2 (en) | 2017-08-31 | 2022-12-01 | Io Therapeutics, Inc. | Rar selective agonists in combination with immune modulators for cancer immunotherapy |
WO2023097259A1 (en) * | 2021-11-23 | 2023-06-01 | Io Therapeutics, Inc. | METHODS OF USING RARγ AGONISTS FOR CANCER TREATMENT |
CN115073394A (en) * | 2022-06-29 | 2022-09-20 | 上海中医药大学 | High allyl compound and preparation method and application thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3202100A1 (en) * | 1982-01-23 | 1983-08-04 | Basf Ag, 6700 Ludwigshafen | SUBSTITUTED 4-HYDROXYANILIDES, ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
US5527945A (en) | 1989-02-10 | 1996-06-18 | Basf Aktiengesellschaft | Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom |
US5324840A (en) | 1992-06-11 | 1994-06-28 | Allergan, Inc. | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
BR9307784A (en) * | 1993-01-11 | 1995-11-14 | Ligand Pharm Inc | Compounds having selectively for retinoid X receptors |
CA2129773C (en) * | 1993-09-02 | 2007-05-01 | Michael Klaus | Aromatic carboxylic acid derivatives |
AU2823395A (en) | 1994-06-07 | 1996-01-04 | Sri International | Novel compounds useful in modulating gene expression of retinoid responsive genes and/or having anti-ap-1 activity |
US5750515A (en) | 1995-04-10 | 1998-05-12 | Taiho Pharmaceutical Co., Ltd. | Cancer metastasis inhibitor |
US5965606A (en) * | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
FR2746098B1 (en) | 1996-03-14 | 1998-04-30 | BIAROMATIC PROPYNYL COMPOUNDS | |
FR2753091B1 (en) | 1996-09-09 | 2001-03-16 | Oreal | USE OF AN RXR-TYPE RETINOID RECEPTOR AGONIST TO STIMULATE OR INDUCE HAIR GROWTH AND / OR STOP THE LOSS |
US5998486A (en) * | 1997-07-08 | 1999-12-07 | Georgetown University School Of Medicine | Treatment of emphysema with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli) |
TWI281911B (en) * | 2000-04-04 | 2007-06-01 | Allergan Inc | Treatment of tumors with RARalpha selective retinoid compounds in combination with other anti-tumor agents |
-
2001
- 2001-09-24 AT AT01969762T patent/ATE413375T1/en active
- 2001-09-24 HU HU0303006A patent/HU230063B1/en unknown
- 2001-09-24 CZ CZ2003-1216A patent/CZ307141B6/en not_active IP Right Cessation
- 2001-09-24 MX MXPA03002861A patent/MXPA03002861A/en active IP Right Grant
- 2001-09-24 PL PL362671A patent/PL208665B1/en unknown
- 2001-09-24 RU RU2003112608/04A patent/RU2282616C2/en active
- 2001-09-24 CN CNB018167098A patent/CN1321101C/en not_active Expired - Lifetime
- 2001-09-24 AU AU8991301A patent/AU8991301A/en active Pending
- 2001-09-24 DE DE60136477T patent/DE60136477D1/en not_active Expired - Lifetime
- 2001-09-24 KR KR1020037004742A patent/KR100682144B1/en active IP Right Grant
- 2001-09-24 ES ES01969762T patent/ES2316471T3/en not_active Expired - Lifetime
- 2001-09-24 JP JP2002532198A patent/JP4118675B2/en not_active Expired - Fee Related
- 2001-09-24 NZ NZ524603A patent/NZ524603A/en not_active IP Right Cessation
- 2001-09-24 EP EP01969762A patent/EP1324970B1/en not_active Expired - Lifetime
- 2001-09-24 SI SI200130886T patent/SI1324970T1/en unknown
- 2001-09-24 IL IL15481001A patent/IL154810A0/en unknown
- 2001-09-24 PT PT01969762T patent/PT1324970E/en unknown
- 2001-09-24 WO PCT/EP2001/011017 patent/WO2002028810A2/en active IP Right Grant
- 2001-09-24 BR BR0114344-1 patent/BRPI0114344B8/en not_active IP Right Cessation
- 2001-09-24 AU AU2001289913A patent/AU2001289913B2/en not_active Expired
- 2001-09-24 DK DK01969762T patent/DK1324970T3/en active
- 2001-09-24 CA CA2422805A patent/CA2422805C/en not_active Expired - Lifetime
- 2001-09-24 RS YUP-244/03A patent/RS50354B/en unknown
- 2001-09-27 JO JO2001155A patent/JO2434B1/en active
- 2001-09-27 AR ARP010104552A patent/AR034156A1/en unknown
- 2001-09-28 MY MYPI20014544A patent/MY137435A/en unknown
- 2001-09-28 PA PA20018529701A patent/PA8529701A1/en unknown
- 2001-10-01 US US09/968,425 patent/US6777418B2/en not_active Expired - Lifetime
- 2001-10-02 GT GT200100199A patent/GT200100199A/en unknown
- 2001-10-02 TW TW090124279A patent/TWI304805B/en not_active IP Right Cessation
-
2003
- 2003-03-06 IL IL154810A patent/IL154810A/en active IP Right Grant
- 2003-03-11 ZA ZA200301978A patent/ZA200301978B/en unknown
- 2003-03-18 EC EC2003004518A patent/ECSP034518A/en unknown
- 2003-03-24 HR HR20030230A patent/HRP20030230B1/en not_active IP Right Cessation
- 2003-04-01 NO NO20031480A patent/NO329113B1/en not_active IP Right Cessation
- 2003-04-01 MA MA27085A patent/MA26950A1/en unknown
-
2004
- 2004-06-15 HK HK04104315A patent/HK1061229A1/en not_active IP Right Cessation
-
2009
- 2009-01-22 CY CY20091100085T patent/CY1109045T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2003112608A (en) | NEW RETINOIDS FOR TREATING EMPHYSEMA | |
KR100196810B1 (en) | Use of droloxifene in the treatment of bone diseases | |
RU96118132A (en) | COMPOUNDS ACTIVE IN THE NEW SITE ON THE RECEPTOR-REGULATED CALCIUM CHANNELS AND USED FOR TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES | |
DE60128258D1 (en) | Indanyl derivatives for the treatment of respiratory diseases | |
RU2006137706A (en) | 9-SUBSTITUTED 8-OXOADADENINE DERIVATIVE | |
TW200524584A (en) | Polymorphic form of n-[(R)-2, 3-dihydroxy-propoxy]-3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide | |
CA2422805A1 (en) | Retinoids for the treatment of emphysema | |
RU2008126245A (en) | COMBINATION OF ACHE INHIBITOR AND 5-NT ANTAGONIST FOR TREATMENT OF COGNITIVE DYSFUNCTION | |
AU2019397436A1 (en) | Cromolyn esters and uses thereof | |
RU2004139122A (en) | DERIVATIVES OF N-BENZOILUREIDOCORIC ACID, METHOD FOR PRODUCING AND USING THEM | |
RU2002101622A (en) | Naphthoquinone derivatives and their use for the treatment and control of tuberculosis | |
JP2004525968A (en) | Compositions containing imidazotriazinone for nasal application | |
WO2022146914A1 (en) | Cromolyn derivatives and uses thereof | |
HRP20100301T1 (en) | Cyclopeptide derivatives with anti-integrin activity | |
RU2004111787A (en) | RETINOID AGONISTS (1), ALKYL UREA DERIVATIVES | |
RU2007111704A (en) | 4 [(2,4-Dichloro-5-methoxyphenyl) amino] -6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic disease | |
RU2004111789A (en) | RETINOID AGONISTS | |
RU2322438C2 (en) | Azaspiro-compounds for pain treatment | |
JP2002363076A (en) | Method for treating tumor using fumagillol derivative | |
US20080146662A1 (en) | Methods and compositions for treatment of cancer pain | |
JP2003267871A (en) | Radiation hazard-preventing agent | |
RU2004109224A (en) | CYCLIC AMINE COMPOUNDS | |
WO2019145784A2 (en) | Combination therapies for multi-drug resistant pathogens | |
RU2004116695A (en) | HETEROCYCLIC RETINOID COMPOUNDS | |
JP2007238613A (en) | Alpha-delta ligand for non-restorative sleep |